Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
The Risk Management Action Milestones table outlines the risk management actions that were proposed for the chemical substance in this batch of the Challenge that met the criteria of section 64 of the Canadian Environmental Protection Act, 1999. These proposed risk management actions were published in the risk management approach document for this substance. For the complete wording of these proposed actions, please refer to the risk management approach document.
One substance in this batch has been included in a final Order to add to Schedule 1 and one substance was proposed to be added to Schedule 1.
Twelve substances in this batch may be addressed through the application of Significant New Activity (SNAc) provisions. Two Orders and one Notice of intent have been published.
| CAS No. | Chemical Substance | Final1 and Proposed2 Orders and RIAS | Public Comments on the Proposed Risk Management Approach | Final Screening Assessment | Proposed Risk Management Approach | Public Comments on the Draft Screening Assessment and Risk Management Scope |
|---|---|---|---|---|---|---|
| 100-44-7 | 1Benzyl chloride | |||||
| 85-86-9 | 2Solvent Red 23 | None | None |
| CAS No. | Chemical Substance | Final Screening Assessment | Public Comments |
|---|---|---|---|
| 1229-55-6 | Solvent Red 1 | ||
| 1937-37-7 | Direct Black 38 | None | |
| 3118-97-6 | Solvent Orange 7 | ||
| 6250-23-3 | Disperse Yellow 23 | None | |
| 6253-10-7 | Disperse Orange 13 | None | |
| 6300-37-4 | Disperse Yellow 7 | None | |
| 6358-57-2 | Acid Red 111 | None | |
| 7147-42-4 | BPAOPB | ||
| 19800-42-1 | Disperse Orange 29 | None | |
| 21811-64-3 | Disperse Yellow 68 | None | |
| 93805-00-6 | MMMP | None | |
| 74-87-3 | Methyl chloride | ||
| 107-05-1 | 3-Chloropropene | ||
| 117-82-8 | DMEP | None | |
| 68515-42-4 | DHNUP | ||
| 6535-42-8 | Solvent Red 3 |
| Date | Substances Affected | Activity |
|---|---|---|
| December 21, 2011 | CAS No. 100-44-7 | Publication in Canada Gazette of final Order adding one substance to Schedule 1. |
| November 26, 2011 | CAS No. 100-44-7 | Publication in Canada Gazette of Notice of intent to amend the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999, and start of 60-day public comment period. |
| October 15, 2011 | CAS No. 85-86-9 | Publication in Canada Gazette of proposed Order adding substance to Schedule 1, and start of 60-day public comment period. |
| September 10, 2011 | CAS Nos. 85-86-9, 19800-42-1, 6358-57-2 and 7147-42-4 | Publication in Canada Gazette of final assessment decision under subsection 77(6). |
| November 10, 2010 | CAS Nos. 107-05-1, 117-82-8, 1937-37-7, 6250-23-3, 6253-10-7, 6300-37-4, 21811-64-3, 93805-00-6, 1229-55-6, 3118-97-6 and 6535-42-8 | Publication in Canada Gazette of Orders amending the DSL to apply the Significant New Activity provisions of CEPA 1999. |
| October 2, 2010 | CAS Nos. 85-86-9, 6358-57-2, 7147-42-4 and 19800-42-1 | Publication in Canada Gazette and start of 60-day public comment period on (a) the draft screening assessments, (b) the proposals to pursue one of the measures as specified under subsection 77(2) and (c) the risk management scope documents. |
| March 6, 2010 | CAS Nos. 1229-55-6, 3118-97-6, 6250-23-3, 6253-10-7, 6300-37-4, 6535-42-8, 21811-64-3 and 93805-00-6 | Publication in Canada Gazette of Notice of intent to amend the DSL to apply the Significant New Activity provisions of CEPA 1999, and start of 60-day public comment period. |
| February 27, 2010 | CAS No. 100-44-7 | Publication in Canada Gazette of proposed Order adding a substance to Schedule 1, and start of 60-day public comment period. |
| November 28, 2009 | 14 of the 18 substances in Batch 6 | Publication in Canada Gazette of final assessment decision under subsection 77(6), release of proposed risk management approach documents, and start of 60-day public comment period on the proposed risk management approach documents. |
| November 28, 2009 | CAS Nos. 107-05-1, 117-82-8 and 1937-37-7 | Publication in Canada Gazette of Notice of intent to amend the DSL to apply the Significant New Activity provisions of CEPA 1999, and start of 60-day public comment period. |
| May 30, 2009 | All Batch 6 substances | Publication in Canada Gazette and start of 60-day public comment period on (a) the draft screening assessments, (b) the proposals to pursue one of the measures as specified under subsection 77(2) and (c) the risk management scope documents. |
| November 27, 2008 | All Batch 6 substances | Deadline for submission of additional information by interested stakeholders, including on the extent and nature of the management/stewardship of Batch 6 substances. |
| September 30, 2008 | All Batch 6 substances | Deadline for submission of information under the section 71 Notice on Batch 6 substances (if no extension granted). |
| May 31, 2008 | All Batch 6 substances | Release of Batch 6 of the Challenge and the accompanying technical documents. |
In September 2011, the final screening assessment reports for the remaining four substances in this batch were released in the
Canada Gazette, Part I: Vol. 145, No. 37 - September 10, 2011 (
PDF Version - 1147 K).
In November 2009, the final screening assessment reports for 14 of the 18 substances in this batch were released in the
Canada Gazette, Part I: Vol. 143, No. 48 - November 28, 2009 (
PDF Version - 1359 K).
The final screening assessments concluded that two substances in this batch meet one or more criteria in section 64 of the Canadian Environmental Protection Act, 1999 (CEPA 1999). The Government proposed to add these substances to Schedule 1 of the Act. Proposed risk management approach documents were also released for the substances in this batch which met the criteria in section 64 of CEPA 1999.
New information was received from industry or interested stakeholders for each of the 18 substances in this batch. In May 2009, the draft screening assessment reports were released and the related Notices were published in the
Canada Gazette, Part I: Vol. 143, No. 22 - May 30, 2009 (
PDF Version - 817 K). Risk management scope documents were also released in conjunction with these publications.
Comments and the Government's response relating to general themes on the draft screening assessment reports and risk management scope documents are summarized in the
Summary of Overarching Public Comments Received on the Draft Screening Assessment Reports and the Risk Management Scope Documents for Batch 6.
In October 2010, a Notice relating to the release of the draft screening assessment reports for the four remaining substances in Batch 6 (CAS Nos. 85-86-9, 6358-57-2, 7147-42-4 and 19800-42-1), was published in the
Canada Gazette, Part I: Vol. 144, No. 40 - October 2, 2010 (
PDF Version - 1571 K).
New content has been added regarding the human health aspects of the assessments and has led to the re-publication of the draft screening assessments on these substances in order to allow a public comment period on the updated content. Risk management scope documents were also released in conjunction with these publications.
Information on substances in this batch was gathered from industry and interested stakeholders through a mandatory survey Notice issued under section 71 of CEPA 1999. They were also invited to complete a voluntary questionnaire.
A Notice related to the launch of Batch 6 was published in May 2008 in the Canada Gazette. The section 71 Notice applied to all 18 substances in this batch.
| Approximate Number | Type of Response |
|---|---|
| 60 | Responses to mandatory section 71 Notice (responses were received relating to 13 substances in the batch) |
| 15 | Requests for extension of the deadline for section 71 Notice responses granted |
| 10 | Voluntary submissions of Questionnaires (Questionnaires were received relating to six substances in the batch) |
| 90 | Expressions of "Stakeholder Interest" (responses were received relating to all substances in the batch) |
| 25 | Other submissions (e.g. studies, additional information) |